| Literature DB >> 29567935 |
Shiqi Bian1, Zhijun Zhu1,2,3, Liying Sun1,4,3, Lin Wei1,2, Wei Qu1,2, Zhigui Zeng1,2, Ying Liu1,2.
Abstract
BACKGROUND Normothermic machine perfusion (NMP) is a novel strategy used for organ preservation. We aimed to determine the overall efficacy of NMP for liver preservation versus traditional static cold storage (CS). MATERIAL AND METHODS We performed a meta-analysis of the literature to evaluate the efficacy of NMP in experimental pig models of liver preservation. We use the standardized mean difference and 95% confidence intervals (CI) to calculate statistics and used the random effects model for the combined analysis of the results. RESULTS A total of 16 studies from 12 published articles were included. The combined results showed that NMP significantly decreased alanine aminotransferase (ALT), aspartate aminotransferase (AST), and hyaluronic acid levels in serum or perfusate, significantly increased bile production, and had a similar 5-7-days survival rate after liver transplantation compared with the CS group. CONCLUSIONS NMP provides superior graft preservation compared with CS in the pig model.Entities:
Mesh:
Year: 2018 PMID: 29567935 PMCID: PMC6248025
Source DB: PubMed Journal: Ann Transplant ISSN: 1425-9524 Impact factor: 1.530
Figure 1Search strategy for selection of studies.
Characteristics of the included studies.
| References | WIT (min) | n (NMP) | Time (NMP) | n (CS) | Time (CS) | Perfusate | Evaluation Method | Observation time | Outcomes |
|---|---|---|---|---|---|---|---|---|---|
| Banan 2016 [ | 0 | 3 | 4 | 3 | 4 | Whole Blood | Reperfusion | 4 h | AST, ALT, Lac, INR, bile production, bile biochemistry, blood gas, β-galactosidase, HA, histological changes, O2 consumption, Vascular compliance |
| Nassar 2016 [ | 60 | 5 | 10 | 5 | 10 | Whole Blood | Reperfusion | 24 h | AST, ALT, GGT, LDH, GGT, bile production, bile biochemistry, histological changes, O2 consumption, Flow/100 g tissue |
| Nassar 2015 [ | 60 | 15 | 10 | 5 | 10 | Whole Blood | Reperfusion | 24 h | AST, ALT, LDH, histological changes |
| Liu 2014 [ | 60 | 5 | 10 | 5 | 10 | Whole Blood | Reperfusion | 24 h | AST, ALT, LDH, Lac, bile production, histological changes, Oxygen consumption, HA and PV pressures and flows |
| Boehnert-a 2013 [ | 60 | 6 | 8 | 6 | 8 | Steen solution | Reperfusion | 12 h | ALT, bile production, bile biochemistry, HA, histological changes, O2 consumption, BUN, CT angiography |
| Boehnert-b 2013 [ | 60 | 6 | 4 | 6 | 4 | Steen solution | OLT | 8 h | AST, bile production |
| Fondevila 2011[ | 90 | 6 | 4 | 6 | 4 | Blood based | OLT | 5 d | AST, LDH, TB, PT, IL-6, TNF, vWF, Glu, weight change of liver, 5d survival |
| Brockmann-a 2009 [ | 0 | 5 | 5 | 5 | 5 | Whole Blood | OLT | 5 d | AST, ALT, HA, histological changes, 5d survival |
| Brockmann-b 2009 [ | 0 | 7 | 20 | 7 | 20 | Whole Blood | OLT | 5 d | AST, ALT, HA, histological changes, Glu consumption, weight change of liver, 5d survival |
| Brockmann-C 2009 [ | 40 | 6 | 20 | 4 | 20 | Whole Blood | OLT | 5 d | AST, ALT, HA, histological changes, 5d survival |
| Reddy 2005 [ | 60 | 5 | 1 | 6 | 1 | Whole Blood | Reperfusion | 23 h | AST, ALT, bile production, β-galactosidase, HA, histological changes, weight change of liver |
| Reddy 2004 [ | 60 | 5 | 4 | 4 | 4 | Whole Blood | Reperfusion | 20 h | AST, ALT, BE, PT, Factor V, Glu, bile production, HA |
| Imber 2002 [ | 0 | 5 | 24 | 5 | 24 | Whole Blood | Reperfusion | 24 h | AST, GGT, free Hb, Urate, PT, Factor V, bile production, histological changes, O2 consumption |
| St Peter 2002 [ | 60 | 4 | 24 | 4 | 24 | Whole Blood | Reperfusion | 24 h | ALT, bile production, histological changes |
| Schon-a 2001 [ | 0 | 6 | 4 | 6 | 4 | Blood based | OLT | 7 d | AST, ALT, INR, HA, Glu, histological changes |
| Schon-b 2001 [ | 60 | 6 | 4 | 6 | 4 | Blood based | OLT | 7 d | AST, ALT, INR, HA, Glu, histological changes |
WIT – warm ischemia time; NMP – normothermic machine perfusion; CS – cold storage; OLT – orthotopic liver transplantation.
Assessment of study quality based on the ARRIVE guidelines.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Quality score | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Banan 2016 | + | + | + | + | + | + | + | + | + | + | + | + | + | − | + | + | − | + | + | + | 18 |
| Nassar 2016 | + | + | + | + | + | + | + | + | − | + | + | + | − | − | − | + | − | + | + | + | 15 |
| Nassar 2015 | + | + | + | + | + | + | + | + | − | − | + | + | − | − | − | + | + | + | − | + | 14 |
| Liu 2014 | + | + | + | + | + | + | + | + | − | + | + | + | + | − | − | + | − | + | + | + | 16 |
| Boehnert 2013 | + | + | + | + | + | − | + | + | − | + | + | + | + | − | − | + | − | + | + | + | 15 |
| Fondevila 2011 | + | + | + | + | + | + | − | − | − | + | + | + | + | − | + | + | − | + | − | + | 14 |
| Brockmann 2009 | − | + | + | + | + | − | + | + | − | + | + | + | − | − | − | + | − | + | + | + | 13 |
| Reddy 2005 | + | + | + | + | + | + | − | + | − | + | + | + | + | − | − | + | − | + | − | + | 14 |
| Reddy 2004 | + | + | + | + | + | + | + | + | − | + | + | + | + | − | − | + | − | + | − | + | 15 |
| Imber 2002 | + | + | + | + | + | + | + | + | − | + | + | + | − | − | − | + | − | + | − | − | 13 |
| St Peter 2002 | + | + | + | + | − | + | + | + | − | + | + | + | + | − | − | + | − | + | + | + | 15 |
| Schon 2001 | + | + | + | + | + | + | + | + | + | + | + | + | − | + | + | + | − | + | − | + | 17 |
Study quality items are (1) title; (2) abstract; (3) background; (4) objectives; (5) ethical statement; (6) study design; (7) experimental procedures; (8) experimental animals; (9) housing and husbandry; (10) sample size; (11) allocation of animals to experimental groups; (12) experimental outcomes; (13) statistical methods; (14) baseline data; (15) numbers analyzed; (16) outcomes and estimation; (17) adverse events; (18) interpretation/scientific implications; (19) generalizability/translation; and (20) funding.
Figure 2Effect of NMP vs. CS preservation on ALT level. Results of meta-analysis according to the random effects model.
Figure 3Effect of NMP vs. CS preservation on AST level. Results of meta-analysis according to the random effects model.
Subgroup analysis of ALT.
| Subgroup | No.of studise | Subtotal SMD (95%CI) | I-squared value | p Value |
|---|---|---|---|---|
| 0 min | 2 | −4.75 (−8.22, −1.28) | 59.6% | 0.116 |
| 60 min | 7 | −3.68 (−4.81, −2.55) | 49.8% | 0.063 |
| 1–4 h | 4 | −3.43 (−4.51, −2.34) | 0.0% | 0.899 |
| 10 h | 3 | −6.42 (−8.98, −3.87) | 0.0% | 0.813 |
| 24 h | 2 | −3.58 (−5.93, −1.24) | 78.4% | 0.055 |
| 4–8 h | 2 | −3.20 (−4.70, −1.69) | 0.0% | 0.971 |
| 20–24 h | 7 | −4.13 (−5.51, −2.75) | 59.7% | 0.021 |
Subgroup analysis of AST.
| Subgroup | No.of studise | Subtotal SMD (95%CI) | I-squared value | p Value |
|---|---|---|---|---|
| 0 min | 2 | −1.70 (−6.82, 3.41) | 86.7% | 0.006 |
| 60–90 min | 8 | −3.70 (−5.37, −2.04) | 83.6% | 0.000 |
| 1–4 h | 7 | −3.51 (−5.79, −1.23) | 88.6% | 0.000 |
| 10 h | 3 | −3.32 (−4.35, −2.30) | 19.8% | 0.287 |
| 4–8 h | 2 | −5.72 (−8.06, −3.39) | 0.0% | 0.422 |
| 20–24 h | 5 | −1.86 (−4.82, 1.09) | 89.9% | 0.000 |
| 5–7 d | 3 | −3.45 (−4.23, −2.67) | 0.0% | 0.541 |
Figure 4Effect of NMP vs. CS preservation on SEC damage. Results of meta-analysis according to the random effects model.
Figure 5Effect of NMP vs. CS preservation on liver synthetic function. Results of meta-analysis according to the random effects model.
Subgroup analysis of bile production.
| Subgroup | No.of studise | Subtotal SMD (95%CI) | I-squared value | p Value |
|---|---|---|---|---|
| 0 min | 2 | 3.38 (1.71, 5.05) | 0.0% | 0.899 |
| 60 min | 8 | 4.22 (1.93, 6.52) | 89.5% | 0.000 |
| 1–4 h | 4 | 2.46 (0.23, 4.69) | 80.0% | 0.002 |
| 8–10 h | 4 | 5.78 (0.83, 10.73) | 92.6% | 0.000 |
| 24 h | 2 | – | – | – |
| 4–12 h | 3 | 0.84 (−0.43, 2.11) | 53.4% | 0.117 |
| 20–24 h | 7 | 5.80 (2.87, 8.72) | 85.9% | 0.000 |
Figure 6Effect of NMP vs. CS preservation on survival rate. Results of meta-analysis according to the random effects model.